BR0214289A - Composição de bebida compreendendo um composto de boro definido, método de preparação da mesma, kit compreendendo a mesma e uso da mesma na fabricação de um medicamento - Google Patents
Composição de bebida compreendendo um composto de boro definido, método de preparação da mesma, kit compreendendo a mesma e uso da mesma na fabricação de um medicamentoInfo
- Publication number
- BR0214289A BR0214289A BR0214289-9A BR0214289A BR0214289A BR 0214289 A BR0214289 A BR 0214289A BR 0214289 A BR0214289 A BR 0214289A BR 0214289 A BR0214289 A BR 0214289A
- Authority
- BR
- Brazil
- Prior art keywords
- compositions
- kit
- preparing
- manufacture
- beverage composition
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 7
- 238000000034 method Methods 0.000 title abstract 3
- 235000013361 beverage Nutrition 0.000 title abstract 2
- 150000001639 boron compounds Chemical class 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title 1
- -1 BORO COMPOUND Chemical class 0.000 abstract 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- 206010003246 arthritis Diseases 0.000 abstract 1
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 230000037180 bone health Effects 0.000 abstract 1
- 229910052796 boron Inorganic materials 0.000 abstract 1
- 230000008821 health effect Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 229940126601 medicinal product Drugs 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/22—Boron compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/54—Mixing with gases
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
"COMPOSIçãO DE BEBIDA COMPREENDENDO UM COMPOSTO DE BORO DEFINIDO, MéTODO DE PREPARAçãO DA MESMA, KIT COMPREENDENDO A MESMA E USO DA MESMA NA FABRICAçãO DE UM MEDICAMENTO". A presente invenção refere-se a composições que contêm boro, as quais são úteis para diversas finalidades, incluindo melhora da saúde óssea, alívio de artrite, dor e inflamação, além de oferecer outros efeitos benéficos à saúde. A presente invenção refere-se também aos métodos para a preparação de tais composições, aos métodos de uso (incluindo a administração) das composições, bem como aos kits contendo as composições. As composições têm um pH que é pelo menos cerca de duas unidades de pH abaixo do pKa do composto de boro.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/989,641 US6632449B2 (en) | 2001-11-20 | 2001-11-20 | Compositions and kits comprising a defined boron compound and methods of their preparation |
PCT/US2002/036531 WO2003043617A1 (en) | 2001-11-20 | 2002-11-15 | Compositions and kits comprising a defined boron compound, methods of their preparation, and use and administration thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0214289A true BR0214289A (pt) | 2004-09-21 |
Family
ID=25535315
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0214289-9A BR0214289A (pt) | 2001-11-20 | 2002-11-15 | Composição de bebida compreendendo um composto de boro definido, método de preparação da mesma, kit compreendendo a mesma e uso da mesma na fabricação de um medicamento |
Country Status (9)
Country | Link |
---|---|
US (1) | US6632449B2 (pt) |
EP (2) | EP1450776A1 (pt) |
JP (1) | JP2005509661A (pt) |
CN (2) | CN1589134A (pt) |
AU (1) | AU2002346396A1 (pt) |
BR (1) | BR0214289A (pt) |
CA (1) | CA2463668C (pt) |
MX (1) | MXPA04004732A (pt) |
WO (1) | WO2003043617A1 (pt) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040253296A1 (en) * | 2002-09-11 | 2004-12-16 | Martin Kenneth A. | Food bar for treating musculoskeletal disorders |
CA2574518A1 (en) * | 2004-10-22 | 2006-04-27 | Shin-Jen Shiao | Pharmaceutical composition and non dependence coffee comprising edible carboxylic acid and/or its acid salt and coffeine |
US8007846B2 (en) | 2006-01-18 | 2011-08-30 | Albion International, Inc. | Mixed amino acid/mineral compounds having improved solubility |
ES2609976T3 (es) * | 2006-01-27 | 2017-04-25 | Yale University | Combinación de sal de cinc y agente anti-H. pylori como inhibidor de acción rápida de la secreción de ácido gástrico |
US20080118603A1 (en) * | 2006-11-21 | 2008-05-22 | Lada Mark W | Nutritional beverage for optimal bone health |
US9877500B2 (en) | 2007-03-14 | 2018-01-30 | Concentrate Manufacturing Company Of Ireland | Natural beverage products |
US8084073B2 (en) | 2007-03-14 | 2011-12-27 | Concentrate Manufacturing Company Of Ireland | Anisic acid modified steviol glycoside sweetened beverage products |
US8277862B2 (en) | 2007-03-14 | 2012-10-02 | Concentrate Manufacturing Company Of Ireland | Beverage products having steviol glycosides and at least one acid |
US9314048B2 (en) | 2007-03-14 | 2016-04-19 | The Concentrate Manufacturing Company Of Ireland | Beverage products with non-nutritive sweetener and bitterant |
US20080226790A1 (en) * | 2007-03-14 | 2008-09-18 | Concentrate Manufacturing Company Of Ireland | Long chain fatty acids for reducing off-taste of non-nutritive sweeteners |
US8277861B2 (en) | 2007-03-14 | 2012-10-02 | Concentrate Manufacturing Company Of Ireland | Beverage products having steviol glycosides and at least one acid |
US8029846B2 (en) | 2007-03-14 | 2011-10-04 | The Concentrate Manufacturing Company Of Ireland | Beverage products |
US20090162484A1 (en) * | 2007-12-21 | 2009-06-25 | The Concentrate Manufacturing Company Of Ireland | Beverage having a non-sweetening amount of a potent natural sweetener |
IT1395957B1 (it) * | 2009-05-19 | 2012-11-02 | Pharmaguida S R L | Uso di una combinazione di d-aspartato e l-aspartato per il trattamento della infertilita' maschile. |
US9399047B2 (en) | 2009-07-23 | 2016-07-26 | U.S. Nutraceuticals, LLC | Composition and method to alleviate joint pain using phospholipids and roe extract |
US8557275B2 (en) | 2009-07-23 | 2013-10-15 | U.S. Nutraceuticals, LLC | Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated EPA and DHA |
US9216164B2 (en) | 2009-07-23 | 2015-12-22 | U.S. Nutraceuticals, LLC | Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated EPA and DHA |
US9913810B2 (en) | 2009-07-23 | 2018-03-13 | U.S. Nutraceuticals, LLC | Composition and method to alleviate joint pain using phospholipids and astaxanthin |
US9402857B2 (en) | 2009-07-23 | 2016-08-02 | U.S. Nutraceuticals, LLC | Composition and method to alleviate joint pain using low molecular weight hyaluronic acid and astaxanthin |
US9238043B2 (en) | 2009-07-23 | 2016-01-19 | U.S. Nutraceuticals, LLC | Composition and method to alleviate joint pain using algae based oils |
EP2512269B1 (en) * | 2009-12-18 | 2016-07-13 | Stokely-Van Camp, Inc. | Protein recovery beverage |
US9763897B2 (en) | 2010-04-30 | 2017-09-19 | U.S. Nutraceuticals, LLC | Therapeutic astaxanthin and phospholipid composition and associated method |
JP2013538823A (ja) * | 2010-09-23 | 2013-10-17 | タタ グローバル ビバレッジ リミテッド | 体力増進用(forstrength)カルシウム強化組成物、栄養補助水、及びその調製方法 |
JP2013538822A (ja) * | 2010-09-23 | 2013-10-17 | タタ グローバル ビバレッジ リミテッド | 三価クロム・ホウ素強化組成物、栄養補助水、及びその調製方法 |
ITAN20110027A1 (it) * | 2011-02-25 | 2012-08-26 | Ht Health Trade S R L | Miscela di principi funzionali atti ad integrare il ferro nella dieta umana. |
DE212015000076U1 (de) * | 2014-03-18 | 2016-12-06 | U.S. Nutraceuticals Llc Dba Valensa International | Zusammensetzung zum Mildern von Gelenkschmerzen mittels niedermolekulargewichtiger Hyaluronsäure und Astaxanthin |
CN106723065A (zh) * | 2017-01-12 | 2017-05-31 | 浙江格蕾斯生物科技有限公司 | 一种维生素d和硼复合营养补充剂 |
Family Cites Families (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2255341A (en) * | 1939-04-13 | 1941-09-09 | Fruit Growers Exchange Ca | Composition of citrus fruit constituents and boric acid and method for making the same |
US2661349A (en) | 1949-02-18 | 1953-12-01 | Nat Starch Products Inc | Polysaccharide derivatives of substituted dicarboxylic acids |
US3455838A (en) | 1966-04-22 | 1969-07-15 | Nat Starch Chem Corp | Method of encapsulating water-insoluble substances and product thereof |
US4338346A (en) | 1978-12-21 | 1982-07-06 | The Procter & Gamble Company | Non-nutritive sweetener |
US4863748A (en) | 1979-08-30 | 1989-09-05 | Herschler R J | Dietary products and uses comprising methylsulfonylmethane |
US4411925A (en) | 1980-01-21 | 1983-10-25 | Pfizer Inc. | Branched amides of L-aspartyl-d-amino acid dipeptides |
US4399163A (en) | 1980-11-05 | 1983-08-16 | Pfizer Inc. | Branched amides of L-aspartyl-D-amino acid dipeptides |
US4423029A (en) | 1981-06-25 | 1983-12-27 | The Procter & Gamble Company | (S)-3-Amino-4-[(S,S)-1-(1-hydroxyethyl)alkyl amino]-4-oxo-butyric acid compounds suitable as non-nutritive sweetners |
US4668525A (en) | 1982-01-05 | 1987-05-26 | Thomas J. Lipton, Inc. | Tea extraction process |
US4460617A (en) | 1982-06-04 | 1984-07-17 | National Starch And Chemical Corp. | Protein-free coffee whitener and method of making same |
US4680193A (en) | 1985-05-08 | 1987-07-14 | Nestec S.A. | Solubilization of tea in cold water with catechin |
US4705691A (en) | 1985-11-18 | 1987-11-10 | The Procter & Gamble Co. | Beverage opacifier |
US4705690A (en) | 1985-11-18 | 1987-11-10 | The Procter & Gamble Co. | Weighting oil substitutes |
US4737375A (en) | 1985-12-26 | 1988-04-12 | The Procter & Gamble Company | Beverages and beverage concentrates nutritionally supplemented with calcium |
US4830716B1 (en) | 1986-07-03 | 1999-12-07 | Albion Int | Preparation of pharmaceutical grade amino acid chelates |
US4994283A (en) | 1987-07-02 | 1991-02-19 | The Procter & Gamble Company | Iron-calcium mineral supplements with enhanced bioavailability |
US4786518A (en) | 1987-07-02 | 1988-11-22 | The Procter & Gamble Company | Iron mineral supplements |
US5118513A (en) | 1987-07-02 | 1992-06-02 | The Procter & Gamble Company | Method for enhancing bioavailability of iron-calcium mineral supplements |
US4786510A (en) | 1987-07-02 | 1988-11-22 | The Procter & Gamble Company | Calcium-iron mineral supplements |
US5314919A (en) | 1987-08-28 | 1994-05-24 | The Procter & Gamble Company | Calcium supplements |
US5128374A (en) | 1987-08-28 | 1992-07-07 | The Procter & Gamble Company | Use of calcium citrate malate for the treatment of osteoporosis and related disorders |
US5225221A (en) | 1987-12-28 | 1993-07-06 | The Procter & Gamble Company | Preparation of calcium-supplemented beverages by dispersing calcium hydroxide in pasteurized juice stream |
US4849220A (en) | 1988-04-20 | 1989-07-18 | The United States Of America As Represented By The Secretary Of Agriculture | Use of boron supplements to increase in vivo production of hydroxylated steroids |
US4935256A (en) | 1989-10-31 | 1990-06-19 | Procter & Gamble Company | Process for making green tea solids |
US5186965A (en) | 1990-06-14 | 1993-02-16 | The Procter & Gamble Company | Calcium citrate malate composition |
US5151274A (en) | 1990-08-06 | 1992-09-29 | The Procter & Gamble Company | Calcium and trace mineral supplements |
US5232709A (en) | 1990-08-06 | 1993-08-03 | The Procter & Gamble Company | Calcium and trace mineral supplements comprising estrogen |
US5108761A (en) | 1990-10-01 | 1992-04-28 | The Procter & Gamble Company | Method of preventing tooth enamel erosion utilizing an acidic beverage containing calcium |
WO1992007475A1 (en) | 1990-10-31 | 1992-05-14 | The Procter & Gamble Company | Calcium fortified sauces |
AU3240193A (en) | 1991-12-26 | 1993-07-28 | Procter & Gamble Company, The | Storage stable calcium-supplemented beverage concentrates |
US5389387A (en) | 1991-12-26 | 1995-02-14 | The Procter & Gamble Company | Storage stable calcium-supplemented beverage concentrates |
US5292729A (en) | 1992-08-14 | 1994-03-08 | Albion International, Inc. | II-bond aromatic vitamin chelates |
EP0665719B1 (en) | 1992-10-21 | 1997-01-15 | The Procter & Gamble Company | Sweetener containing a concentrated bioavailable calcium source |
EP0665720B1 (en) | 1992-10-21 | 1996-07-10 | The Procter & Gamble Company | Storage stable calcium-supplemented beverage premix concentrates and syrups |
ATE198122T1 (de) | 1992-10-21 | 2001-01-15 | Procter & Gamble | Konzentrierte, bioverfügbare kalziumquelle |
US5433965A (en) | 1993-02-16 | 1995-07-18 | The Procter & Gamble Company | Beverage compositions and sweetening compositions which contain juice derived from botanical subfamily Cucurbitaceae |
US5364845C1 (en) * | 1993-03-31 | 2002-09-10 | Nutramax Lab Inc | Glusosamine chondroitin and manganese composition for the protection and repair of connective tissue |
US5424082A (en) | 1994-03-03 | 1995-06-13 | The Proctor & Gamble Company | Calcium and vitamin C containing beverage products with improved color stability |
US5474793A (en) | 1994-05-10 | 1995-12-12 | Meyer; Larry E. | Process for preparing calcium-supplemented not-from-concentrate fruit juice beverages |
US5516925A (en) | 1994-08-23 | 1996-05-14 | Albion International, Inc. | Amino acid chelates having improved palatability |
IL115241A (en) | 1994-09-26 | 2000-08-31 | American Cyanamid Co | Calcium dietary supplement |
US5571441A (en) | 1994-11-01 | 1996-11-05 | The Procter & Gamble Company | Nutrient supplement compositions providing physiologic feedback |
US5612026A (en) | 1996-01-25 | 1997-03-18 | The Procter & Gamble Company | Cholesterol lowering drink mix compositons |
US5670344A (en) | 1996-02-02 | 1997-09-23 | The Procter & Gamble Company | Preventing undesired color formation in iron fortified chocolate-flavored beverages by including edible acids or their salts |
US6063428A (en) | 1996-02-26 | 2000-05-16 | The Procter & Gamble Company | Green tea extract subjected to cation exchange treatment and nanofiltration to improve clarity and color |
US5707670A (en) | 1996-08-29 | 1998-01-13 | The Procter & Gamble Company | Use of bilayer forming emulsifiers in nutritional compositions comprising divalent mineral salts to minimize off-tastes and interactions with other dietary components |
US5962049A (en) * | 1997-03-31 | 1999-10-05 | Miljkovic; Dusan | Boron carbohydrate complexes and uses thereof |
US6007856A (en) | 1997-08-08 | 1999-12-28 | The Procter & Gamble Company | Oil-in-water dispersions of β-carotene and other carotenoids stable against oxidation prepared from water-dispersible beadlets having high concentrations of carotenoid |
US6475539B1 (en) * | 1998-05-07 | 2002-11-05 | Abbott Laboratories | Nutritionally complete low pH enteral formula |
US6162787A (en) * | 1999-04-02 | 2000-12-19 | Immudyne, Inc. | Methods for treating arthritis using collagen type II, glucosamine chondroitin sulfate, and compositions |
US6458383B2 (en) * | 1999-08-17 | 2002-10-01 | Lipocine, Inc. | Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin |
US6413558B1 (en) * | 1999-07-19 | 2002-07-02 | The Proctor & Gamble Co. | Compositions, kits, and methods for providing and maintaining energy and metal alertness |
US20020132780A1 (en) * | 2001-01-12 | 2002-09-19 | Heisey Matthew Thomas | Low carbohydrate compositions, kits thereof, and methods of use |
-
2001
- 2001-11-20 US US09/989,641 patent/US6632449B2/en not_active Expired - Lifetime
-
2002
- 2002-11-15 EP EP02784461A patent/EP1450776A1/en not_active Withdrawn
- 2002-11-15 BR BR0214289-9A patent/BR0214289A/pt not_active Application Discontinuation
- 2002-11-15 MX MXPA04004732A patent/MXPA04004732A/es active IP Right Grant
- 2002-11-15 EP EP10012625A patent/EP2266551A1/en not_active Withdrawn
- 2002-11-15 CA CA2463668A patent/CA2463668C/en not_active Expired - Fee Related
- 2002-11-15 AU AU2002346396A patent/AU2002346396A1/en not_active Abandoned
- 2002-11-15 CN CNA028229673A patent/CN1589134A/zh active Pending
- 2002-11-15 WO PCT/US2002/036531 patent/WO2003043617A1/en active Application Filing
- 2002-11-15 CN CNA2008102152249A patent/CN101371710A/zh active Pending
- 2002-11-15 JP JP2003545298A patent/JP2005509661A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CA2463668A1 (en) | 2003-05-30 |
MXPA04004732A (es) | 2004-07-30 |
WO2003043617A1 (en) | 2003-05-30 |
US6632449B2 (en) | 2003-10-14 |
JP2005509661A (ja) | 2005-04-14 |
CA2463668C (en) | 2010-06-15 |
EP1450776A1 (en) | 2004-09-01 |
AU2002346396A1 (en) | 2003-06-10 |
CN1589134A (zh) | 2005-03-02 |
EP2266551A1 (en) | 2010-12-29 |
US20030096794A1 (en) | 2003-05-22 |
CN101371710A (zh) | 2009-02-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0214289A (pt) | Composição de bebida compreendendo um composto de boro definido, método de preparação da mesma, kit compreendendo a mesma e uso da mesma na fabricação de um medicamento | |
BR9714082A (pt) | Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto. | |
BR9911482A (pt) | Composto, composição farmacêutica, uso do composto, e, processos para o tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto | |
BR0214705A (pt) | Composição, seu uso, método para prevenção ou tratamento de doença neurodegenerativa, e kit | |
RS20090083A (en) | Novel medicament compositions, based on anticholinergically effective compounds and beta -mimetics | |
BR9714055A (pt) | Composto, uso do mesmo, agente de diagnóstico, composição farmacêutica, e, processos para a preparação de um composto, para o tratamento da dor, tratamento de distúrbios gastrointestinais e de ferimentos na coluna vertebral. | |
BR0213612A (pt) | Composto, composição farmacêutica, uso do composto e método para tratamento de doença ou condição | |
ECSP034732A (es) | Derivado de fenetanolamina para el tratamiento de enfermedades respiratorias | |
SE0104340D0 (sv) | New compounds | |
BG105005A (en) | Pyrazoline derivatives, their preparation and application as medicaments | |
UY24354A1 (es) | Composiciones farmacéuticas que contienen epinastina | |
BRPI0215312B8 (pt) | composto, uso de um composto, composição farmacêutica, e processo para a preparação de um composto | |
BR9713785A (pt) | Composto, uso do mesmo, agente de diagnóstico, composição farmacêutica, e, processos para a preparação de um composto e para o tratamento da dor, de distúrbios gastrointestinais e de lesões na coluna vertebral. | |
AR023574A1 (es) | Compuestos de azepinindol tetraciclico,composiciones farmaceuticas y el uso de dichos compuestos para preparar un medicamento, e intermediarios | |
PT1326613E (pt) | Utilizacao de derivados de imidazo[1,2-a]piridin-,imidazo[1,2-a]pirimidin- e imidazo[1,2-a]pirazin-3-il-amina substituidos para a fabricacao de medicamentos para inibicao de nos | |
DE69940769D1 (de) | Orale flüssige zusammensetzungen | |
BR0012590A (pt) | Composto, processo para a preparação do mesmo, formulação farmacêutica, uso de um composto, e, métodos para tratamento ou profilaxia de dor ou desconforto, e para tratamento ou profilaxia de dor neuropática ou central | |
BR9912240A (pt) | Benzocicloheptenos, processo para a sua preparação, preparados farmacêuticos, que contêm os mesmos bem como seu emprego para a preparação de medicamentos | |
BRPI0407253A (pt) | Heterociclil-3-sulfonilindazóis como ligandos 5-hidroxitriptamina-6 processo de preparação dos mesmos, seus usos na preparação de uma composição farmacêutica e composição farmacêutica compreendendo os referidos compostos | |
BR0206935A (pt) | Composto, formulação farmacêutica, uso de um composto, método de tratamento e/ou profilaxia de condições associadas com a inibição da glicogênio sintase quinase-3, e, processo para a preparação de um composto | |
BRPI0406717A (pt) | Composto, composição farmacêutica que compreende o mesmo, método de tratamento de uma enfermidade em um mamìfero, utilização do composto e processo para a sua produção | |
BR0109672A (pt) | Uso de zd6126 ou de um seu sal farmaceuticamente aceitável e um de: um agente antitumoral de plantina e um taxano, composição farmacêutica, produto de combinação, kit, e, método para a produção de um efeito de danificação vascular em um animal de sangue quente | |
HUP0100539A2 (hu) | D-vitamint és kálciumot tartalmazó gyógyászati készítmények és eljárás azok előállítására | |
BR9909211A (pt) | Combinações farmacêuticas com tramadol | |
GR1004358B (el) | Ανυδρη κρυσταλλικη μορφη της βαλακyκλοβιρης υδροχλωρικης |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25A | Requested transfer of rights approved |
Owner name: SD IP HOLDINGS COMPANY (US) Free format text: TRANSFERIDO DE: THE PROCTER AND GAMBLE COMPANY |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Free format text: PARA INT.CL: A61K 31/00, A23L 1/30, A23L 2/00, A61K 33/22, A23L 1/304, A61P 19/00, A61P 269/00 Ipc: A61K 31/00 (2011.01), A23L 1/30 (2011.01), A23L 2/ |
|
B11E | Dismissal acc. art. 34 of ipl - requirements for examination incomplete | ||
B15K | Others concerning applications: alteration of classification |
Ipc: A61K 33/22 (2006.01), A23L 2/02 (2006.01), A23L 2/ |
|
B11T | Dismissal: dismissal of application maintained |